Tosymra™

Tosymra™
Product Description

Tosymra™ is an FDA-approved, nasal spray formulation of sumatriptan utilizing Intravail™ technology as a permeation enhancer, resulting in more complete and rapid absorption of sumatriptan as compared to other nasal formulations.

Upsher-Smith Laboratories

  • US
  • 2018
    On CPHI since
Specifications
  • Supplied from
    United States

Upsher-Smith Laboratories

  • US
  • 2018
    On CPHI since

More Products from Upsher-Smith Laboratories (1)

  • Zembrace®

    Product Zembrace®

    Zembrace® is a subcutaneous injection formulation of sumatriptan offering the lowest available dose of 3 mg of sumatriptan in a compact, easy to use auto-injection device which is currently on-market in the US.